Psychiatric drugs and driving performance - results of experimental studies

被引:0
|
作者
Grass, H [1 ]
Berghaus, G [1 ]
机构
[1] Klinikum Univ Koln, Inst Rechts Med, D-50823 Cologne, Germany
关键词
psychiatric drugs; traffic safety;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Due to the effects of psychiatric drugs (tranquilizer, antidepressants and neuroleptics), especially sedation, it is to be expected that they impair performance (attention, concentration, reaction time etc.) that is indispensable for driving safely. This expectation is verified in experimental studies. The duration and intensity of performance depend essentially on the substance, the dosage, the space of time between application and driving' the duration of therapy and the strength of the basic illness. The intensity of impairment is highest at the beginning of the therapy, at this time, the degree of impairment equals the deficits concerned by more than 0.05% alcohol. The impairment decreases with increasing time of treatment. The danger to traffic safety will be minimized by appropriate prescription (substance and dose), useful hints to the patient and optimal behavior of the patient concerning driving in relation to drug intake.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 50 条
  • [21] Effects of Lasmiditan on Driving Performance: Results of 2 Randomized, Blinded, Crossover Simulated Driving Studies with Placebo and Active Controls
    Pearlman, E. M.
    Doty, E. Gautier
    Dennehy, E. B.
    Wilbraham, D.
    Tsai, M.
    Berg, P. H.
    Kay, G. G.
    HEADACHE, 2019, 59 : 22 - 22
  • [22] Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance
    Iwata, Mari
    Iwamoto, Kunihiro
    Kitajima, Iwao
    Nogi, Takasuke
    Onishi, Koichi
    Kajiyama, Yu
    Nishino, Izumi
    Ando, Masahiko
    Ozaki, Norio
    PSYCHOPHARMACOLOGY, 2021, 238 (03) : 775 - 786
  • [23] Protocol for the development and validation of a driving simulator for evaluating the influence of drugs on driving performance
    Iwata, Mari
    Iwamoto, Kunihiro
    Omura, Tomohiro
    Ando, Masahiko
    Ozaki, Norio
    MEDICINE, 2019, 98 (08)
  • [24] Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance
    Mari Iwata
    Kunihiro Iwamoto
    Iwao Kitajima
    Takasuke Nogi
    Koichi Onishi
    Yu Kajiyama
    Izumi Nishino
    Masahiko Ando
    Norio Ozaki
    Psychopharmacology, 2021, 238 : 775 - 786
  • [25] EFFECTS OF 2 ANTIHISTAMINE DRUGS ON ACTUAL DRIVING PERFORMANCE
    COHEN, AF
    POSNER, J
    BRITISH MEDICAL JOURNAL, 1984, 288 (6421): : 935 - 935
  • [26] EFFECTS OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS ON DRIVING PERFORMANCE
    HERBERG, KW
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (41): : 1163 - 1165
  • [27] EFFECTS OF 2 ANTIHISTAMINE DRUGS ON ACTUAL DRIVING PERFORMANCE
    BETTS, T
    MARKMAN, D
    DEBENHAM, S
    MORTIBOY, D
    MCKEVITT, T
    BRITISH MEDICAL JOURNAL, 1984, 288 (6413): : 281 - 282
  • [28] Drugs and driving research: Application of results by drug regulatory authorities
    De Gier, JJ
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 : S133 - S136
  • [30] Antidepressive drugs - Results of studies with mirtazapine
    Oberpichler-Schwenk, H
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 79 - 80